Overview and Scope
Immunoassay is a bioanalytical test that employs antibody attachment to antigens to detect and quantify specific chemicals. Diseases can be diagnosed using immunoassays. Furthermore, information from test findings concerning an illness may be used to establish a course of therapy. This technique relies primarily on a competitive binding response for a finite number of receptors on an extremely specific anti-analyte antibody between a set quantity of labelled versions of an analyte and a substantial portion of an unmarked sample analyte.
Sizing and Forecast
The immunoassay market size has grown strongly in recent years. It will grow from $34.75 billion in 2023 to $36.79 billion in 2024 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to disease prevalence, aging population, infectious disease outbreaks, point-of-care testing, increased research funding ..
The immunoassay market size is expected to see strong growth in the next few years. It will grow to $47.01 billion in 2028 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to personalized medicine, expansion in emerging markets, pandemic preparedness, cancer diagnostics, shift to home-based testing.. Major trends in the forecast period include regulatory harmonization efforts, multipurpose immunoassays, customized assay services, integration with wearable devices, miniaturization of assays..
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report
Segmentation & Regional Insights
The immunoassay market covered in this report is segmented –
1) By Product: Reagents And Kits, Analyzers Or Instruments, Software And Services
2) By Specimen: Blood, Saliva, Urine, Other Specimens
3) By Application: Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications
4) By End User: Research And Academic Laboratories, Home Care Settings, Pharmaceutical And Biotechnology Companies And CROs, Blood Banks, Hospitals And Clinics, Clinical Laboratories
North America was the largest region in the immunoassay market in 2023. Asia-Pacific is expected to be the fastest-growing region in the immunoassay market report during the forecast period. The regions covered in the immunoassay market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=9838&type=smp
Major Driver Impacting Market Growth
The increasing numbers of infectious and chronic illnesses are expected to propel the growth of the immunoassay market in the coming future. Chronic illnesses are characterized generically as those that persist for a year or more, need continuous medical care, restrict everyday activities, or both. Infectious illnesses are ailments caused by organisms such as bacteria, viruses, fungi, or parasites. Numerous creatures inhabit and dwell on the human body. Several infectious illnesses can be transmitted from person to person. Immunoassay is employed to detect several infectious and chronic diseases. For instance, according to a report published by the National Institutes of Health (NIH), a US-based biomedical research agency, in 2023, in the United States, the number of people aged 50 and older with at least one chronic illness is predicted to rise by 99.5%, from 71.522 million in 2020 to 142.66 million in 2050. Additionally, the number of people with multimorbidity would rise by 91.16% from 7.8304 million in 2020 to 14.968 million in 2050. Therefore, the increasing number of infectious and chronic illnesses is driving the market.
Key Industry Players
Major companies operating in the immunoassay market report are Siemens Healthineers GmbH, bioMérieux, Abbott, Beckman Coulter Inc., Quidel Corporation, Ortho Clinical Diagnostics, Sysmex Corporation, Bio-Rad Laboratories Inc., Becton Dickinson and Company, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc., WAK-Chemie Medical GmbH, J Mitra & Co Pvt Ltd., Kamiya Biomedical Company, Tosoh Corporation, Gyros Protein Technologies AB, BioCheck Inc., Bio-Techn, DiaSorin S.p.A, Meso Scale Diagnostics LLC, QIAGE, Randox Laboratories Ltd., Shenzhen Mindray Bio-Medical Electronics Co Ltd., Danaher Corporation, Hologic Inc., Tecan Trading AG, Eurofins Scientific, Abcam PLC, Enzo Biochem Inc., Luminex Corporation, Quanterix Corporation, Roche Diagnostics, Waters Corporation, ZEUS Scientific Inc. .
The immunoassay market report table of contents includes:
1. Executive Summary
2. Immunoassay Market Characteristics
3. Immunoassay Market Trends And Strategies
4. Immunoassay Market – Macro Economic Scenario
5. Global Immunoassay Market Size and Growth
.
.
.
31. Global Immunoassay Market Competitive Benchmarking
32. Global Immunoassay Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Immunoassay Market
34. Immunoassay Market Future Outlook and Potential Analysis
35. Appendix
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
